Chronix to Use SOLiD 4 Sequencer for Biomarker Discovery | GenomeWeb

This article has been updated to correct the name of Chronix's CEO.

Chronix Biomedical said this week that it has gained access to a Life Technologies SOLiD 4 sequencer that was recently installed at the University of Göttingen, a Chronix collaborator.

Chronix said it will use the sequencer to accelerate its development of serum DNA biomarkers related to various cancers and chronic diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.